Articles From: Biggest Banks Lag Behind as Economy Gains Steam to BIND Therapeutics to Present at Oppenheimer 25th Annual Healthcare Conference


2015/1/15
By Christina Rexrode And Saabira Chaudhuri More than five years into the economic recovery, the nation's biggest banks are still on the outside looking in, as their fortunes grow increasingly disconnected from the rest of the country's.
Sign-up for Biggest Banks Lag Behind as Economy Gains Steam investment picks
2014/12/31
By William Watts, MarketWatch Not everyone will benefit from falling fuel prices Oil prices plunged around 50% from their June peak by the end of 2014, the fastest collapse since the dark days of 2008.
Sign-up for Biggest potential losers of the 2014 oil plunge investment picks
http://media.marketwire.com/attachments/201201/5267_marinsoft_logo_rgb.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1160427&ProfileId=051205&sourceType=1 SAN FRANCISCO, CA --
Sign-up for Biggest Social Geek 2014: Winners Announced investment picks
2014/11/22
SAN ANTONIO , Nov.
Sign-up for Biglari Holdings Inc. News Release investment picks
2014/12/2
bigtincan , a mobile content enablement company, and AT&T* are working together to provide a solution designed to help sales and service organizations improve worker productivity.
Sign-up for bigtincan and AT&T Drive Productivity Through Enterprise-Grade Mobile Content Management investment picks
2014/12/2
New Application Creates a Mobile-First Experience for Businesses to Create, Edit and Share Content Across Its Mobile Workforce WALTHAM, Mass.
Sign-up for bigtincan and AT&T Drive Productivity Through Enterprise-Grade Mobile Content Management investment picks
- $42.3 Million Refund to Company - 4,650 Prospective Acres Retained DENVER , Nov.
Sign-up for Bill Barrett Corporation Announces Successful Settlement on Cottonwood Gulch Asset investment picks
DENVER , Dec.
Sign-up for Bill Barrett Corporation Announces Upcoming Investor Events investment picks
DENVER , Jan.
Sign-up for Bill Barrett Corporation Announces Upcoming Investor Events investment picks
Bill Carew, managing principal of Digital Benefit Advisor’s (DBA) ( digitalbenefitadvisors.com ) Hartford, Conn.
Sign-up for Bill Carew Named Senior Vice President of Growth for Digital Benefit Advisors investment picks
2014/11/20
By Mark DeCambreSoros approached Gross about putting money with Janus: Reuters NEW YORK (MarketWatch) -- Bill Gross just got a $500-million vote of confidence from one of Wall Street's most recognizable investors.
Sign-up for Bill Gross just scored a huge vote of confidence at his new fund investment picks
2014/10/28
By Ben Eisen, MarketWatch NEW YORK (MarketWatch) -- Less money, fewer problems.
Sign-up for Bill Gross likely took a big pay cut to join Janus investment picks
2015/1/13
By Wallace Witkowski, MarketWatch Gross tells Bloomberg he still has something to prove SAN FRANCISCO (MarketWatch) -- Bond guru Bill Gross admitted he was "blindsided" when Pimco, the firm he helped start, fired him last year.
Sign-up for Bill Gross says he was 'blindsided' by Pimco firing investment picks
2014/12/15
The Federal Reserve might hold back from hiking interest rates in 2015 because of a lack of inflation, said bond guru Bill Gross in a CNBC interview on Monday.
Sign-up for Bill Gross: Disinflation may stop Fed from 2015 rate hike investment picks
By Kirsten Grind Bill Gross isn't yet attracting investors in droves to his new home.
Sign-up for Bill Gross's new Janus fund took in $364 million in his first month investment picks
2014/12/5
ADVISORY, Dec.
Sign-up for BillerudKorsnas AB to Ring The Nasdaq Stock Market Closing Bell investment picks
Fiserv, Inc. (NASDAQ: FISV), a leading global provider of financial services technology solutions, today announced that Consolidated Edison of New York (Con Edison), the electric, gas and steam utility in New York City and Westchester County, New York, has implemented BillMatrix ® Payments from Fiserv.
Sign-up for BillMatrix Payments from Fiserv Enables Visa Card Payments for Con Edison Customers investment picks
2014/10/31
Biloxi Marsh Lands Corporation (PINK SHEETS: BLMC) today announces its unaudited results for the third quarter of 2014 and first nine months of 2014 and provides update.
Sign-up for Biloxi Marsh Lands Corporation Announces Unaudited Results for the Third Quarter and First Nine Months of 2014 and Provides Update investment picks
2014/12/11
During its meeting held today the Board of Directors of Biloxi Marsh Lands Corporation (Pink Sheets: BLMC) declared a dividend of $.40 per outstanding share of common stock payable on Tuesday, December 30, 2014 to shareholders of record as of the close of business on Monday, December 22, 2014.
Sign-up for Biloxi Marsh Lands Corporation Declares Cash Dividend investment picks
BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins TM , today announced a joint research and development agreement with Merck, known as MSD outside the United States and Canada, through a subsidiary, to discover and develop novel nanomedicines for oncology.
Sign-up for BIND Therapeutics Announces Agreement with Merck to Develop Targeted Accurin™ Nanomedicines for Oncology investment picks
BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins TM , announced the online availability of an abstract providing preliminary data from the Q3W arm of its ongoing Phase 2 study of BIND-014 in non-small cell lung cancer (NSCLC). Data included in the abstract were current as of the submission deadline on June 13, 2014 and updated data will be presented in a poster presentation on November 19, 2014 at the 26 th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain.
Sign-up for BIND Therapeutics Announces Availability of Abstract with Preliminary Data from Phase 2 Study of BIND-014 in Non-small Cell Lung Cancer investment picks
BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins TM , today announced the appointment of Hagop Youssoufian, M.Sc., M.D., as Chief Medical Officer.
Sign-up for BIND Therapeutics Appoints Hagop Youssoufian, M.Sc., M.D. as Chief Medical Officer investment picks
BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins TM , today presented positive results from its ongoing Phase 2 study of BIND-014 in non-small cell lung cancer (NSCLC), demonstrating it has met the primary objective in the once every three weeks (Q3W) arm as measured by overall response rate (ORR). The data demonstrate that BIND-014 is well-tolerated with clinically meaningful anti-tumor activity at a lower dose than conventional docetaxel in patients with advanced or metastatic NSCLC.
Sign-up for BIND Therapeutics Presents Positive Phase 2 Results Highlighting Potential of BIND-014 as Novel Anti-Cancer Treatment at Q3W Dosing Schedule for Patients with Non-small Cell Lung Cancer at 26th EORTC-NCI-AACR Annual Symposium investment picks
BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins™, today announced its 2015 strategic overview and enrollment of the first patient expressing a KRAS mutation in a global, multicenter two-tiered phase 2 trial with BIND-014 in non-small cell lung cancer (NSCLC) patients with KRAS mutant tumors (mutated Kirsten ras oncogene homolog) or squamous histology.
Sign-up for BIND Therapeutics Provides Clinical Update for BIND-014 and 2015 Strategic Overview investment picks
BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins™, today reported financial results and business highlights for the third quarter ended September 30, 2014.
Sign-up for BIND Therapeutics Reports Third Quarter 2014 Financial Results and Provides Corporate Update investment picks
BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins TM , announced today that Scott Minick, BIND’s President and CEO, is scheduled to present at the following healthcare conferences during November 2014: Interested parties may access a live webcast of the presentation by visiting the BIND Therapeutics website at www.bindtherapeutics.com .
Sign-up for BIND Therapeutics to Present at November Healthcare Conferences investment picks
BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins TM , announced today that Scott Minick, BIND’s President and CEO, is scheduled to present at the Oppenheimer 25 th Annual Healthcare Conference in New York on Thursday, December 11, 2014 at 3:55 p.m. EST.
Sign-up for BIND Therapeutics to Present at Oppenheimer 25th Annual Healthcare Conference investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Biggest Banks Lag Behind as Economy Gains Steam to BIND Therapeutics to Present at Oppenheimer 25th Annual Healthcare Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent